A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

NCT01371708 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
283
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer